| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.23 | 4e-06 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0002 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.098 | 0.0009 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0009 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.17 | 0.002 |